Glucose Control in Type 2 Diabetes in Pregnancy
Part of paid clinical trials in Norfolk, Virginia.
- Sponsor
- Eastern Virginia Medical School
- Study ID
- NCT07250698
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pregestational Diabetes
- Type 2 Diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exercise — BEHAVIORALThis intervention consists of instructions to walk for 20 minutes after each meal.
Study Details
The goal of this clinical trial is to evaluate the effect of physical activity on glucose control in pregnant patients with pregestational Type 2 diabetes. The main question it seeks to answer is "will physical activity following a meal improve blood sugar control in pregnant women with Type 2 diabetes?" Researchers will compare the glucose control of two groups: one that walks for 20 minutes after each meal, and one that does not.
Key Dates
- Start date
- Dec 31, 2025
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Post-prandial walkParticipants in this arm of the study will be instructed to walk for 20 minutes after each meal (breakfast, lunch, and dinner). They will also be given a continuous glucose monitor and a FitBit, to wear throughout their participation in the study.
- No Intervention: Standard of CareParticipants in this arm will be given the regular counseling on the importance of exercise during pregnancy, but not instructed to walk after each meal. They will receive a continuous glucose monitor and FitBit to wear throughout their participation in the study.
Primary Outcome Measure
Blood Glucose Time in Range [ Time Frame: Between 34 and 36 weeks gestation. ]
Central Contacts
- Marwan Ma'ayeh, MD757-446-7900
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Eastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University | Norfolk | Virginia | 23507 |
Find similar trials in Norfolk, VA
Related Studies
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness DiabetesRecruiting · University of Colorado, Denver · Aurora, Colorado
- Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle ModificationRecruiting · Chiara Fabris, PhD · Aurora, Colorado
- Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes ManagementPHASE4 · Recruiting · Eastern Virginia Medical School · Norfolk, Virginia
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)PHASE2 · Recruiting · Sparrow Pharmaceuticals · Chandler, Arizona